Código QR (código de barras bidimensional)

Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis – a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial

BackgroundUlcerative colitis (UC) is a chronic inflammatory bowel disease with a complex etiology that affects the large intestine. Characterized by chronic, bloody diarrhea, UC can lead to severe complications, including an increased risk of colorectal cancer. Despite advancements in conservative t...

ver descrição completa

Na minha lista:
Principais autores: Renata Talar-Wojnarowska, Adam Fabisiak, Hubert Zatorski, Katarzyna Płoszka, Katarzyna Błaziak, Wojciech Fendler, Grażyna Rydzewska, Ewa Małecka-Wojciesko, Piotr Eder
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2024-09-01
coleção:Frontiers in Medicine
Assuntos:
inflammatory bowel diseases
ulcerative colitis
dual biological therapy
infliximab
ustekinumab
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fmed.2024.1458998/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados